Bahrain has approved the Oxford-AstraZeneca Covid-19 vaccine for emergency use, state news agency BNA reported on Monday, citing the Gulf country's National Health Regulatory Authority.
Covid-19: Bahrain approves Oxford-AstraZeneca vaccine for emergency use
BNA
Photo: Reuters
The Oxford-AstraZeneka vaccine is the third to be approved by Bahrain for emergency use following Sinopharm and Pfizer.
The National Health Regulatory Authority has approved the emergency use of Covishield, the Covid-19 vaccine produced by AstraZeneka in cooperation with the University of Oxford and manufactured at the Serum Institute of India (SII), the world s largest vaccine manufacturer.
Bahrain joins the list of countries that have authorized the emergency use of the vaccine for the groups at highest risks of developing complications from the coronavirus, including the elderly, people with chronic diseases, and other groups determined by the Ministry of Health.
Bahrain approves use of Oxford/AstraZeneca COVID-19 vaccine timeoutbahrain.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timeoutbahrain.com Daily Mail and Mail on Sunday newspapers.